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The autoimmune disease systemic lupus erythe-
matosus is characterized by high titers of serum 
IgG autoantibodies to nuclear antigens (Sherer 
et  al.,  2004).  Anti–double-stranded  DNA 
(dsDNA) and anti-nucleosome IgG antibodies 
are hallmark lupus autoantibodies in mice and 
humans, which correlate with clinical symptoms 
and contribute to renal pathology (Reveille, 
2004). Ig gene analysis of monoclonal anti- 
nuclear antibodies (ANAs) from autoimmune 
mice and humans has shown that the majority 
of these antibodies carry somatic mutations and 
show signs of antigen-mediated selection, sug-
gesting  that  they  developed  in  response  to   
antigenic stimulation (Shlomchik et al., 1987, 
1990; van Es et al., 1991; Winkler et al., 1992; 
Wellmann et al., 2005; Mietzner et al., 2008). 
Because somatic mutations and affinity matura-
tion are hallmark features of T cell–dependent 
germinal center (GC) reactions, it has been   
inferred  that  these  autoantibodies  develop  in 
GCs. However, in all studies reported to date 
autoantibodies were obtained from hybridomas 
or EBV transformed stable cell lines and, there-
fore the precise origin of the cells that expressed 
the autoantibody and whether or not they arose 
in GCs in vivo is not known.
The  IgG  inhibitory  Fc    receptor  IIB 
(FcRIIB) plays an important role in maintain-
ing self-tolerance (Tarasenko et al., 2007). Low 
levels of FcRIIB, which negatively regulates 
activating FcR-mediated signals in myeloid 
cells and antigen receptor-mediated signals in   
B cells, are associated with lupus in mice and 
humans (Jiang et al., 1999, 2000; Pritchard   
et al., 2000; Qin et al., 2000; Ravetch and   
Bolland, 2001; Rao et al., 2002; Rahman and 
Manser, 2005; Mackay et al., 2006; Rahman   
et al., 2007b; Su et al., 2007; Lee et al., 2009). 
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Abnormalities in expression levels of the IgG inhibitory Fc gamma receptor IIB (FcRIIB)  
are associated with the development of immunoglobulin (Ig) G serum autoantibodies and 
systemic autoimmunity in mice and humans. We used Ig gene cloning from single isolated  
B cells to examine the checkpoints that regulate development of autoreactive germinal 
center (GC) B cells and plasma cells in FcRIIB-deficient mice. We found that loss of 
FcRIIB was associated with an increase in poly- and autoreactive IgG+ GC B cells,  
including hallmark anti-nuclear antibody–expressing cells that possess characteristic  
Ig gene features and cells producing kidney-reactive autoantibodies. In the absence of 
FcRIIB, autoreactive B cells actively participated in GC reactions and somatic mutations 
contributed to the generation of highly autoreactive IgG antibodies. In contrast, the  
frequency of autoreactive IgG+ B cells was much lower in spleen and bone marrow  
plasma cells, suggesting the existence of an FcRIIB-independent checkpoint for  
autoreactivity between the GC and the plasma cell compartment.
© 2010 Tiller et al.  This article is distributed under the terms of an Attribution–
Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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Fig. S1, A–C). All FcRIIB/ mice showed autoimmunity 
with high serum IgG anti-dsDNA and anti-nucleosome   
autoantibody titers, splenomegaly, increased frequencies of 
splenic GC B cells and plasma cells in spleen and bone marrow, 
and IgG immune complex deposition in the kidney (Fig. S1 
and Table S1). GL7+Fas+IgD GC B cells resembled normal 
GC B cells in that they were located exclusively within the folli-
cle and frequently expressed IgG2b/c antibodies (Fig. S1 D).   
Out of 811 single B cells, we amplified 70 different VH region 
genes from 9 out of 16 different families and 67 different V 
region genes belonging to 16 out of 19 different families 
demonstrating the unbiased amplification of the expressed 
C57BL/6 V gene repertoire by our nested PCR strategy 
(Fig. 1 and Tables S2–S4; Tiller et al., 2009). Major consis-
tent differences in the VH and JH gene usage, V and J 
gene usage, DH gene usage, IgH CDR3 length, and IgG 
subclass distribution between wild-type and FcRIIB/ 
mice or between GC B cells and spleen and bone marrow 
plasma cells were not observed (Fig. 1, A–F; and Figs. S2 and S3). 
However, FcRIIB/ mice showed a significant increase 
in DH gene reading frame (RF) 1 usage associated with 
decreased RF2 usage as compared with wild-type mice (P = 
0.003; Fig. 1 D), and IgG antibodies from GC B cells of 
FcRIIB/ mice showed, on average, significantly lower 
numbers of VH gene somatic mutations than wild-type GC 
B cells (Fig. 1 G). FcRIIB/ GC B cells were also signifi-
cantly enriched for antibodies with highly positively charged 
IgH CDR3, a feature which is associated with antibody auto-
reactivity (Fig. 1 H; Barbas et al., 1995; Casali and Schettino, 
1996). The high frequency of positively charged amino acids 
in IgH CDR3 of FcRIIB/ GC B cells was not associated 
with abnormalities in Ig DH gene hydrophobic RF usage 
(Fig. 1 D and Fig. S2 D).
In summary, the presence of serum IgG autoantibodies in 
FcRIIB/ mice was not associated with a general skewing 
of the Ig gene repertoire. However, GC B cells of FcRIIb/ 
mice showed lower numbers of somatic mutations, and IgG 
antibodies with highly positively charged IgH CDR3 were en-
riched in GC B cells but not in spleen or bone marrow plasma 
cells compared with wild-type controls.
IgG+ FcRIIB/ GC B cells with positively charged  
IgH CDR3 accumulate over time and are associated  
with disease progression
Despite the early presence of IgG serum autoantibodies, only 
20% of FcRIIB/ mice develop T cell–dependent dis-
ease symptoms, including high anti-DNA serum IgG levels, 
splenomegaly, and nephritis, and die from kidney failure by 
the age of 9 mo (Fig. 2 A and not depicted). To determine if 
changes in the IgG+ GC B cell repertoire are detectable be-
fore the onset of overt disease, we analyzed the Ig gene reper-
toire and IgH CDR3 of GC B cells from three FcRIIB/ 
mice with modest increase in spleen size and low or undetect-
able levels of serum IgG autoantibodies for the presence of 
positively charged amino acids (Fig. 2 and Tables S1 and S4). 
No differences in IgH or Ig gene usage between nondiseased 
Mice  deficient  for  FcRIIB  spontaneously  develop  high   
serum IgG ANAs with age, which precedes the onset of nephri-
tis in a strain-specific manner (Bolland and Ravetch, 2000). 
FcRIIB is expressed on myeloid cells and B cells, but B cell–
specific overexpression of FcRIIB is sufficient to reduce IgG 
autoantibody levels, lupus-like disease, and mortality, thus 
demonstrating the B cell–intrinsic importance of FcRIIB for 
the regulation of autoreactive B cells (McGaha et al., 2005; 
Brownlie et al., 2008). A role for FcRIIB in maintaining pe-
ripheral self-tolerance at the plasma cell level was suggested by 
the finding that loss of FcRIIB leads to expansion of IgG+ 
spleen and bone marrow plasma cells and hypergammaglobu-
linemia (Fukuyama et al., 2005; Rahman et al., 2007b; Xiang   
et al., 2007). However, the role of FcRIIB in regulating auto-
reactive GC B cells has only been explored in Ig gene trans-
genic mouse models (Paul et al., 2007; Rahman et al., 2007a). 
Thus, how loss of FcRIIB expression influences the fre-
quency at which autoreactive and ANA-expressing B cells 
participate in GC reactions and develop into plasma cells 
under physiological conditions is unknown.
To address this question and to determine the frequency 
of autoreactive GC B cells and plasma cells in mice with an 
unrestricted antibody repertoire, we analyzed the GC B cell 
and spleen and bone marrow plasma cell antibody repertoire 
in FcRIIB/ mice and healthy C57BL/6 control mice. 
Cloning and expression of 360 monoclonal antibodies from 
single cells revealed that FcRIIB/ GC B cells are enriched 
for somatically mutated self-reactive antibodies including 
high-affinity anti-dsDNA and kidney-specific autoantibodies. 
Such antibodies were also detected in the plasma cell com-
partment of FcRIIB/ mice but at much lower frequency 
than in GC B cells. Increased frequencies of GC B cells with 
positively charged IgH complementarity determining region 
(CDR) 3 were associated with high IgG serum anti-DNA   
autoantibody levels and disease progression, but anti-nuclear 
and anti-kidney reactive GC B cells were present at high fre-
quency even in mice with low anti-DNA IgG serum levels.   
In wild-type mice, low-level self-reactive and polyreactive anti-
bodies were expressed by spleen plasma cells, but high-affinity 
lupus-associated IgG autoantibodies were not detected. In sum-
mary, our data demonstrate a role for FcRIIB in the develop-
ment and differentiation of autoreactive GC B cells and provide 
direct proof that dsDNA self-reactive B cells participate in GC 
reactions in diseased animals. In addition, we demonstrate that 
FcRIIB-independent  self-tolerance  mechanisms  dominate 
the regulation of self-reactive GC B cells before differentiation 
into plasma cells.
RESULTS
FcRIIB/ GC B cells are enriched for IgGs  
with charged IgH CDR3s
To compare the wild-type and FcRIIB/ B cell reper-
toires, we isolated single IgM+ mature naive and IgG+ GC   
B cells from spleen and plasma cells from spleen and bone 
marrow of six 4–8-mo-old autoimmune FcRIIB/ mice 
(1RII–3RII and 5RII–7RII) and of three controls (1B6–3B6;   JEM VOL. 207, November 22, 2010 
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with positively charged IgH CDR3 (P = 0.348 as compared 
with B6 and P = 0.044 as compared with diseased FcRIIB/ 
mice). To further determine if increased frequencies of GC   
B cells with positively charged IgH CDR3 are a general feature 
of strong active GC responses, we analyzed IgG+ GC B cells 
and diseased FcRIIB/ mice or nondiseased FcRIIB/ 
mice and wild-type mice were observed (Tables S2–S4 and not 
depicted). Despite high numbers of GC B cells, FcRIIB/ 
mice with low or negative anti-DNA serum IgG levels 
showed no significant increase in the frequency of GC B cells 
Figure 1.  Ig gene analysis of mature naive B cell, GC B cell, and plasma cell antibodies from wild-type and FcRIIB/ mice. Data shown 
summarize the IgH and Ig gene sequence analysis of 717 antibodies from single IgM+ mature naive B cells and IgG+ GC B cells and spleen and bone 
marrow plasma cells of six FcRIIB/ mice (black; Table S2, 1RII–3RII and 5RII–7RII) and three wild-type mice (white; Table S3, 1B6–3B6). (A) IgH V gene 
family and J gene usage. (B) Ig V gene family and J gene usage. (C and D) Ig DH gene (C) and Ig DH gene RF (D) usage. (E) IgH CDR3 amino acid length. 
Horizontal lines indicate the mean IgH CDR3 amino acid length. (F) IgG1, IgG2c, IgG2b, and IgG3 isotype subclass distribution. (G) Number of somatic 
mutations in individual IgH V genes from FWR1 to FWR3, inclusively, of IgM+ mature naive B cells, IgG+ GC B cells, and IgG+ spleen and bone marrow 
plasma cells of FcRIIB/ (filled circles) and wild-type (open circles) mice. Horizontal lines indicate the mean number of somatic mutations. (H) Fre-
quency of IgH CDR3s with zero (white), one (light gray), two (dark gray), or three and greater than three (black) positive charges in IgM+ mature naive  
B cells, IgG+ GC B cells, and IgG+ spleen and bone marrow plasma cells from FcRIIB/ and wild-type mice. The numbers of IgH sequences analyzed are 
indicated in the pie chart centers. P-values were calculated by Fisher’s exact 2 × 5 test for DH gene and DH gene RF usage and IgG subclass distribution 
or Student’s t test for IgH CDR3 amino acid length and somatic mutations but did not show significant differences between FcRIIB/ and wild-type 
mice (A–G). P-values for the analysis of IgH CDR3-positive charges in H were calculated by Fisher’s exact 2 × 5 test and are indicated for the comparison 
of GC B cells to mature naive B cells and pooled spleen and bone marrow plasma cells from FcRIIB/ (top) and C57BL/6 mice (bottom), respectively, and 
for the comparison of mature naive B cells, GC B cells, spleen plasma cells, and bone marrow plasma cells between FcRIIB/ and C57BL/6 mice (center).2770 FcRIIB regulates germinal center B cells | Tiller et al.
(Tables S2–S4). Clonal relatives were frequently distributed 
between the spleen and bone marrow plasma cell compart-
ments in wild-type and FcRIIB/ mice, but little clonal 
overlap was observed between the GC and spleen or bone 
marrow plasma cell pool (Tables S2 and S3). Thus, the GC 
and plasma cell antibody repertoires are distinct and show 
limited clonal diversity irrespective of FcRIIB expression.
Increased frequencies of polyreactive IgG+ B cells  
in FcRIIB/ mice
Serum IgG autoantibodies and antibodies, which deposit in 
the kidney of lupus mice, are frequently polyreactive and 
show cross-reactivity with diverse self- and foreign antigens 
(Table S1; Pankewycz et al., 1987; Deshmukh et al., 2006). 
To measure the frequency of polyreactive IgG+ plasma cells 
and to determine if polyreactive B cells participate in GC re-
actions, we cloned and expressed the IgH and matching Ig 
chains from GC B cells and spleen and bone marrow plasma 
cells from FcRIIB/ and control mice. The recombinant 
monoclonal  antibodies  were  assayed  for  polyreactivity  by 
ELISA with three structurally diverse individual antigens:   
dsDNA, insulin, and LPS (Fig. 3 and Tables S2 and S3;   
Wardemann et al., 2003). IgG+ GC B cell antibodies and 
bone marrow plasma cell antibodies from FcRIIB/ mice 
were more frequently polyreactive with all tested antigens 
than the wild-type control antibodies (Fig. 3 B; 35 and 14% 
in FcRIIB/ GC and bone marrow plasma cells, respec-
tively, and 4 and 3% in wild-type GC and bone marrow 
plasma cells, respectively). In contrast, spleen plasma cells fre-
quently expressed polyreactive antibodies in wild-type (18%) 
and FcRIIB/ (23%) mice, suggesting that the spleen is a 
reservoir of polyreactive plasma cells under normal circum-
stances and polyreactive spleen plasma cells are not strongly 
increased in the absence of FcRIIB (Fig. 3 B). Sequence 
analysis showed that antibody polyreactivity was not associ-
ated with mutation levels or clonal expansion, and clonal rel-
atives  with  different  somatic  mutation  patterns  frequently 
varied in their antibody polyreactivity (Tables S2 and S3). 
Thus, loss of FcRIIB is associated with increased numbers 
of polyreactive IgG+ GC B cells and bone marrow plasma 
cells, but splenic plasma cells frequently express polyreactive 
antibodies even in wild-type mice.
Nucleosome-reactive GC and plasma cell antibodies  
in FcRIIB/ mice
To  measure  the  frequency  of  anti-nucleosome  IgG+  GC   
B cells and plasma cells, we analyzed the recombinant antibodies 
from FcRIIB/ and control mice for nucleosome reactiv-
ity by ELISA (Fig. 4). Antibodies with low-level nucleosome 
reactivity were found at similar frequency in plasma cells of 
FcRIIB/ and wild-type mice (Fig. 4; 29 and 31% for 
spleen plasma cells and 18 and 16% for bone marrow plasma 
cells of FcRIIB/ and wild-type mice, respectively). In con-
trast, 15% of FcRIIB/ GC B cells but only 4% of wild-type 
GC B cells showed low nucleosome reactivity (Fig. 4 A).   
To determine if the frequency of nucleosome-reactive GC 
from wild-type mice at different time points (days 10, 14, and 
21) after immunization with OVA in CFA, which contains a 
complex mixture of mycobacterial antigens (Fig. 2). Immuni-
zation of wild-type mice did not increase the frequency of 
IgG+ GC B cells with highly positively charged IgH CDR3s 
as compared with nonimmunized wild-type mice (P = 0.109). 
We conclude that increased frequencies of GC B cells with 
positively charged IgH CDR3 are associated with high levels 
of anti-DNA serum IgG and the development of overt dis-
ease symptoms in FcRIIB/ mice and are not a general 
feature of active inflammatory GC responses to diverse for-
eign antigens.
Limited diversity in antigen-experienced B cells from  
wild-type and FcRIIB/ mice
It has been suggested that serum IgG autoantibodies in sys-
temic lupus erythematosus are the products of clonally ex-
panded plasma cells, which originate from GC reactions in 
response to T cell–dependent stimulation (Shlomchik et al., 
1990). Autoimmune FcRIIB/ mice showed splenomeg-
aly and increased numbers of GC B cells and plasma cells in 
secondary lymphoid organs and bone marrow, respectively 
(Table S1). We therefore determined the degree of clonality 
by Ig gene sequence analysis. Single GC B cells and spleen 
and bone marrow plasma cells of individual C57BL/6 and 
FcRIIB/ mice frequently expressed Ig genes with identi-
cal IgH VDJ and Ig VJ rearrangements but varying levels of 
somatic mutations, indicating that they were clonally related 
Figure 2.  Increased frequency of GC B cells with positively 
charged IgH CDR3 are associated with lupus disease in FcRIIB/ 
mice. Bar graphs compare the frequency of IgH CDR3s with zero (white), 
one (light gray), two (dark gray), or greater than or equal to three (black) 
positive charges in 237 IgG+ GC B cells from six FcRIIB/ mice (1RII–3RII 
and 5RII–7RII; Table S1) with overt lupus disease, as measured by high 
anti-dsDNA IgG serum levels (dsDNA+) to IgG+ GC B cells from three 
FcRIIB/ mice (4RII, 8RII, and 9RII) with low or negative anti-dsDNA 
serum IgGs (dsDNA+/; n = 97; Table S1) and to IgG+ GC B cells from  
three wild-type mice at days 10, 14, and 21 after immunization with OVA 
in CFA (n = 174; Table S1). Error bars indicate standard deviation of 
means. GC B cells with positively charged IgH CDR3 were significantly 
enriched in FcRIIB/dsDNA+ mice as compared with FcRIIB/ 
dsDNA+/ mice (P = 0.008) and to immunized wild-type mice (P = 0.007).  
GC B cells from FcRIIB/dsDNA+/ mice were not significantly different 
from immunized wild-type mice (P = 0.109). P-values were calculated by 
Fisher’s exact 2 × 5 test.JEM VOL. 207, November 22, 2010 
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nucleosome-reactive spleen and bone marrow plasma cells, 
respectively, were polyreactive in FcRIIB/ mice (Tables S2 
and S4). In wild-type mice, 33% of nucleosome-reactive 
spleen plasma cells, but none of the bone marrow plasma cell 
antibodies, were polyreactive, thus confirming the result that 
polyreactivity is enriched in the spleen plasma cell compart-
ment but not in bone marrow plasma cells under normal cir-
cumstances (Table S3).
In summary, low-affinity nucleosome-reactive IgG antibod-
ies constitute part of the normal plasma cell compartment, but 
they were rare in GC B cells from wild-type mice independently 
of ongoing active immune responses to foreign antigens. Loss of 
FcRIIB is associated with increased numbers of nucleosome-
reactive GC B cells, including those producing highly reactive 
antibodies. These antibodies were also found among plasma cells 
in FcRIIB/ mice but were not detected in wild-type mice.
B cells in wild-type mice increased in active GC responses to 
foreign antigens, we cloned, expressed, and tested 80 anti-
bodies from IgG+ GC B cells at days 10, 14, and 21 after im-
munization with OVA in CFA for nucleosome reactivity 
(Fig. 4 B). OVA/CFA immunization was not associated with 
increased frequencies of nucleosome-reactive GC B cells. Fur-
thermore, IgG antibodies with high levels of anti-nucleosome 
reactivity (OD405 > 1.5× higher than the internal positive con-
trol) were only detected in FcRIIB/ GC and plasma cells 
and not in control cells (Fig. 4). Thus, nucleosome-reactive 
GC B cells are enriched only in the absence of FcRIIB   
(P = 0.001 as compared with nonimmunized and immunized 
wild-type controls).
Anti-nucleosome reactivity has been associated with anti-
body polyreactivity (Mortensen et al., 2008). Indeed, 69%   
of nucleosome-reactive GC antibodies and 48 and 38% of 
Figure 3.  Polyreactivity of IgG+ antibodies from GC B cells and plasma cells from FcRIIB/ and wild-type mice. (A) Antibodies cloned (black 
lines) from IgG+ GC B cells and spleen and bone marrow plasma cells of FcRIIB/ (1RII–5RII) and wild-type (1B6–3B6) mice were tested for polyreac-
tivity with dsDNA, insulin, and LPS by ELISA. Graphs show OD405 values at 1 µg/ml antibody concentration and three consecutive 1:4 dilutions of repre-
sentative antibodies. Dashed lines represent the highly polyreactive positive control antibody ED38 (Wardemann et al., 2003). Red lines represent the 
low-polyreactive positive control antibody JB40 and green lines represent the nonpolyreactive negative control antibody mGO53 (Wardemann et al., 
2003). (B) Pie charts summarize the frequency of nonpolyreactive antibodies (white) and polyreactive antibodies (black) in the respective compartments. 
All antibodies were tested in at least three independent experiments. The numbers of antibodies analyzed are indicated in the pie chart centers. P-values 
were calculated by Fisher’s exact 2 × 2 test.2772 FcRIIB regulates germinal center B cells | Tiller et al.
In summary, self-reactive antibodies constitute part of the 
normal GC B cell and plasma cell repertoire, but ANAs are rare 
and those that exist do not show chromatin reactivity. In con-
trast,  highly  autoreactive  anti-dsDNA  and  anti-nucleosome 
IgG2b and IgG2c with positively charged IgH CDR3 and other 
chromatin  and  non-chromatin–reactive  ANAs  were  cloned 
from GC B cells and plasma cells of autoimmune FcRIIB/ 
mice with serum antibodies of the same specificity. Thus, the 
overall frequency of ANAs was high in FcRIIB/ GC B cells 
but low in the plasma cell compartments.
FcRIIB/ GC B cells frequently express  
kidney-reactive autoantibodies
The presence of serum autoantibodies in FcRIIB/ mice is 
associated with immune complex deposition in the kidney 
and  precedes  the  development  of  nephritis  (Ehlers  et  al., 
2006). By IFA with mouse kidney and control stomach sec-
tions, we found kidney-specific IgG autoantibodies to be ex-
pressed consistently by GC B cells of FcRIIB/ mice (12%) 
and at lower frequency by spleen (2%) and bone marrow 
plasma cells (3%; Fig. 6). The antibodies recognized different 
kidney structures including the glomeruli. Sequence analysis 
showed that some of the kidney-specific antibodies in one   
of the FcRIIB/ animals belonged to an expanded clone 
comprising six IgG2c spleen and bone marrow plasma cell 
antibodies with varying levels of somatic mutations (Fig. S4 and 
Table S2). Kidney-reactive GC and plasma cell antibodies 
FcRIIB/ GC B cells are enriched for ANAs
IgG ANAs are a hallmark of systemic lupus disease. These   
antibodies were found in the serum of the autoimmune 
FcRIIB/ mice analyzed in this study by indirect immuno-
fluorescence assay (IFA) on the human larynx carcinoma cell 
line HEp-2 (Fig. S1 E). To determine the frequency of GC   
B cells and plasma cells expressing ANAs and to characterize 
their staining pattern, we tested all monoclonal antibodies by 
IFA with HEp-2 cells (Fig. 5, A–C). Various nuclear, cyto-
plasmic, and nuclear plus cytoplasmic HEp-2 cell antibody 
staining patterns were detected in wild-type and FcRIIB/ 
mice. However, the overall frequency of IgG ANAs was con-
sistently higher in GC B cells of all FcRIIB/ mice (16%) 
as compared with GC B cells from immunized and nonim-
munized wild-type controls (3%; P = 0.005; Fig. 5 B and not 
depicted). Furthermore, antibodies with a homogenous chro-
matin staining pattern, as judged by Hoechst costaining, were 
only found in FcRIIB/ mice (Fig. 5, A and C). Two such 
antibodies with high numbers of positively charged amino   
acids in IgH CDR3 (1RIIgc7 and 1RIIspc194; Fig. 5 D) were 
further tested for dsDNA reactivity by IFA with the flagellate 
Crithidia luciliae (Fig. 5 D). Antibody 1RIIgc7, but not 1RII-
spc194, showed kinetoplast staining indicating reactivity with 
native dsDNA, and neither reacted with histones (Fig. 5 D and 
not depicted). Thus, antibody 1RIIgc7 and antibody 1RIIspc194 
are IgG lupus autoantibodies with specificity for dsDNA and   
nucleosomes, respectively.
Figure 4.  Nucleosome reactivity of IgG+ antibodies from GC B cells and plasma cells of FcRIIB/ and wild-type mice. Antibodies cloned 
from IgG+ GC B cells and spleen and bone marrow plasma cells of FcRIIB/ mice (1RII–5RII) and nonimmunized and OVA/CFA immunized wild-type 
(1B6–6B6) mice were tested for nucleosome reactivity by ELISA. (A) Data shown are normalized relative units (RU) of OD405 values at 3 µg/ml antibody 
concentrations for representative antibodies from FcRIIB/ and nonimmunized wild-type animals. Normalization was relative to the OD405 values of the 
internal positive control, which was set to 1. Dots represent individual antibodies. Dashed lines indicate 0.5 and 1.5× RU values of the positive control.  
The clone names of highly nucleosome reactive antibodies are indicated in the graphs. (B) Pie charts summarize the frequency of non-nucleosome– 
reactive (white; <0.5× RU value of positive control), low nucleosome-reactive (gray; 0.5–1.5× RU value of positive control), and high nucleosome-reactive 
antibodies (black; >1.5× RU value of positive control) in the respective compartments and mice. Data are representative of at least two independent  
experiments. The number of tested antibodies is indicated in the pie chart center. P-values were calculated by Fisher’s exact 2 × 5 test.JEM VOL. 207, November 22, 2010 
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somes (1RIIspc194), respectively. The sixth 
antibody  (lnpc203)  was  an  IgG  rheumatoid 
factor  antibody  from  a  FcRIIB/  lymph 
node plasma cell with high specificity to IgG2c 
as measured by ELISA and surface plasmon 
resonance (Fig. 7 C and not depicted). IgG 
rheumatoid factor antibodies were also present 
in the serum of two FcRIIB/ mice ana-
lyzed in this study. Five out of the six auto-
antibodies tested showed partial or complete loss of specificity 
and/or reactivity in the absence of somatic mutations (Fig. 7,   
B–E). For example, kidney reactivity of GL 1RIIgc58 was no 
longer limited to the glomeruli and, in contrast to their mutated 
counterparts, GL 2RIIspc95 and GL 1RIIbmpc19 lacked reac-
tivity to defined stomach and kidney structures (Fig. 7 B). Loss 
of reactivity was also observed for the GL form of the anti-
nucleosome antibody 1RIIspc194, and antibody lnpc203 lacked 
IgG2c rheumatoid factor reactivity in the absence of somatic 
mutations (Fig. 7, C and D). Only antibody 1RIIgc7 showed no 
measurable changes in ELISA reactivity to dsDNA in the ab-
sence of somatic mutations (Fig. 7 E). However, dsDNA reac-
tivity was dependent on two non-GL Ig gene encoded arginine 
residues at the V-D and D-J junction in IgH CDR3 (Table S5). 
dsDNA reactivity of GL 1RIIgc7 was abrogated if the two argi-
nines, which may be the product of somatic mutations, were re-
placed by serine residues (Fig. 7 E; GL 1RIIgc7S). In summary, 
we conclude that the GC B cells and plasma cells expressing 
highly reactive T cell–dependent IgG autoantibodies in 
FcRIIB/ mice can develop from non-self–reactive or low 
affinity self-reactive precursors by somatic mutation in GCs.
were rare in healthy mice. Immunization of wild-type mice 
did not increase the frequency of kidney-specific GC B cells 
(P = 0.002 vs. FcRIIB/; unpublished data). In contrast, 
stomach-specific autoantibodies and antibodies reactive with 
autoantigens in both tissues were found at similar frequency 
in GC B cells and plasma cells of FcRIIB/ and wild-type 
mice (Fig. 6 B and Tables S2 and S3). We conclude that kidney-
specific autoantibodies are rare under normal circumstances 
but are enriched in the GC B cell and plasma cell compartment 
in autoimmune FcRIIB/ mice.
Somatic mutations in autoantibodies from FcRIIB/ mice
T cell help is required for the development of IgG serum auto-
antibodies and disease symptoms in FcRIIB/ mice (Fig. 7 A). 
To determine the role of somatic mutations in autoreactivity, 
we cloned and expressed the unmutated IgH and IgL V(D)J 
germline (GL) versions of six FcRIIB/-derived GC B cell 
and plasma cell autoantibodies (Fig. 7, B–E; and Table S5). 
Three of the antibodies were specific for unknown kidney (1RI-
Igc58 and 1RIIbmpc19) and stomach (2RIIspc95) autoantigens 
and two antibodies recognized dsDNA (1RIIgc7) and nucleo-
Figure 5.  ANAs are enriched in GC B cells of 
FcRIIB/ mice. (A) Antibodies cloned from IgG+ 
GC B cells and spleen and bone marrow plasma cells 
of FcRIIB/ (1RII–5RII) and wild-type (1B6–3B6) 
mice were tested for self-reactivity with HEp-2 cells 
by IFA. Examples of typical nonreactive antibodies, 
anti-cytoplasmic, anti-nuclear + cytoplasmic, and 
anti-nuclear HEp-2 cell staining patterns at 40× 
magnification are shown. Staining patterns of reac-
tive antibodies were confirmed in at least two inde-
pendent experiments. Bars, 25 µm. (B) Pie charts 
summarize the frequency of non–HEp-2 self-reactive 
(white) GC B cells and spleen and bone marrow 
plasma cell antibodies of wild-type and FcRIIB/ 
mice and of antibodies with nuclear (black), cytoplas-
mic (light gray), and nuclear + cytoplasmic (dark 
gray) HEp-2 cell staining patterns. The numbers of 
antibodies analyzed are indicated in the pie chart 
centers. (C) Strong homogenous nuclear HEp-2 cell 
staining patterns of IgG+ FcRIIB/ GC B cell anti-
body 1RIIgc7 and spleen plasma cell antibody 1RII-
spc194. Nuclei are visualized by Hoechst staining. 
Bars, 25 µm. (D) Crithidia luciliae IFA staining pattern 
at 100× magnification of the same antibodies as in C. 
Nuclei and kinetoplasts are shown by Hoechst stain-
ing. Bars, 10 µm. Data shown are representative of at 
least two independent experiments.2774 FcRIIB regulates germinal center B cells | Tiller et al.
in FcRIIB/ mice carrying a 3H9 anti-DNA 
IgH chain knockin allele (Paul et al., 2007).
Previous studies have also reported IgH CDR3 
abnormalities in anti-dsDNA antibodies from lupus-
prone mice, including D-D fusions and hydrophobic 
DH RF usage (Radic et al., 1989). However, atypi-
cal V-D-J rearrangements are not a general feature of 
ANAs, and FcRIIB-deficient mice on a C57BL/6 
background showed low hydrophobic RF usage and lacked   
D-D fusions. Thus, they may not be prone for the generation or 
selection of self-reactive B cells with atypical V-D-J rearrange-
ments (Shefner et al., 1991; Ash-Lerner et al., 1997; Mueller   
et al., 1997; Klonowski et al., 1999).
A role for somatic mutations in the generation of autoan-
tibodies, including polyreactive and anti-dsDNA antibodies, 
has been described previously in mice and humans (Diamond 
and Scharff, 1984; Shlomchik et al., 1987, 1990; van Es et al.,   
1991; Wellmann et al., 2005; Tiller et al., 2007; Mietzner et al., 
2008). However, as a result of the use of stable cell lines, 
the origin of the cells expressing the autoantibodies was not 
known and studies in humans were limited to the memory   
B cell compartment. Thus, the question of whether the auto-
reactive B cells originated from GC or extrafollicular responses 
in vivo has not been answered. Our antibody cloning strategy 
now demonstrates that IgG autoantibodies, including ANAs 
and kidney-specific autoantibodies, are expressed by GC 
B cells in FcRIIB/ mice and that somatic mutations con-
tribute to the generation of high-affinity IgG autoantibodies,   
which can develop from non-self–reactive and self-reactive   
precursors. Indeed, replacement of non-GL–encoded arginine 
residues abrogated dsDNA reactivity of antibody 1RIIgc7. 
As a result of terminal deoxynucleotidyl transferase–induced 
nontemplate nucleotides in CDR3, reversion experiments 
of Ig gene segment somatic mutations can never provide 
definite answers on the reactivity of the naive precursor   
B cell. Thus, our experiments cannot preclude that abnormal   
selection of self-reactive precursors contributes to the in-
creased frequency of poly- and self-reactive GC B cells 
in FcRIIB/ mice. However, somatic mutations play 
DISCUSSION
Previous  studies  analyzed  Ig  gene-targeted  mice  carrying   
autoreactive antigen receptors to determine how FcRIIB 
suppresses the activation of autoreactive B cells (Paul et al., 
2007; Rahman et al., 2007a). However, presumably as a   
result of differences in the level of self-tolerance in naive   
B cells in the respective models, the results failed to demon-
strate a clear role for FcRIIB in regulating autoreactive   
GC B cells as opposed to the regulation of extrafollicular   
antibody-forming cells. Although diseased FcRIIB-deficient 
mice with an unrestricted antibody repertoire showed no 
general defect in Ig gene recombination or early steps in B cell 
selection in our single cell analysis, GC B cells were signifi-
cantly enriched for ANAs with positively charged IgH CDR3 
and polyreactive and kidney-reactive autoantibodies. Thus, 
FcRIIB is essential to suppress the emergence of autoreactive 
GC B cells.
GC  B  cells  with  positively  charged  IgH  CDR3  were   
associated with high anti-DNA autoantibody levels and were 
not significantly increased in the absence of overt disease 
symptoms as measured by high serum anti-DNA IgG levels 
and splenomegaly, suggesting that such B cells accumulate 
over time and are associated with the onset of lupus symp-
toms. However, non-chromatin–reactive ANAs lacking posi-
tively charged IgH CDR3s and kidney- and polyreactive GC 
antibodies were also observed at high frequency in the absence 
of high serum anti-DNA IgG levels, suggesting that anti-
DNA–reactive GC B cells accumulate over time. Indeed, 
progressive loss of self-tolerance with age, as measured by loss 
of follicular exclusion, increased plasma cell frequencies, and 
accumulation of IgG serum autoantibodies, has been observed 
Figure 6.  Kidney-reactive autoantibodies are enriched 
in GC B cells of FcRIIB/ mice. (A) Antibodies cloned 
from IgG+ GC B cells and spleen and bone marrow plasma 
cells of FcRIIB/ (1RII–5RII) and wild-type (1B6–3B6) mice 
were tested for self-reactivity with mouse kidney (K) and 
stomach (S) tissue sections by IFA. Examples of typical stain-
ing patterns at 20× magnification from antibodies with spe-
cific kidney or stomach reactivity or with kidney plus stomach 
reactivity are shown. Data shown are representative of at 
least two independent experiments. Bars, 100 µm. (B) Pie 
charts summarize the frequency of IgG+ GC B cells and spleen 
and bone marrow plasma cell antibodies from FcRIIB/ and 
wild-type mice lacking tissue reactivity (white) or showing 
kidney + stomach (light gray), stomach (dark gray), and kidney 
(black) tissue staining patterns. The numbers of antibodies 
analyzed are indicated in the pie chart centers.JEM VOL. 207, November 22, 2010 
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B cells via toll-like receptors (Leadbetter et al., 2002; Lau   
et al., 2005; Avalos et al., 2010).
Surprisingly, the frequency of polyreactive and autoreac-
tive B cells was lower in the plasma cell compartments than 
in GCs of FcRIIB/ mice, suggesting that autoreactive 
GC B cells are still partly regulated based on their antibody 
reactivity independently of FcRIIB and before differentia-
tion into plasma cells. Slow differentiation rates of GC B cells 
into plasma cells may prevent the frequent detection of clon-
ally expanded B cells in the GC and in the plasma cell com-
partment at the same time (Takahashi et al., 1998). However, 
little overlap of clonally related cells between the GC B cell 
and plasma cell repertoires may also reflect the fact that high 
antibody affinity is a prerequisite for the differentiation of GC 
B cells into plasma cells (Shih et al., 2002; Phan et al., 2006; 
Tarlinton et al., 2008). Therefore, in analogy to humoral im-
mune responses to foreign antigens, only GC B cells express-
ing  high-affinity  autoantibodies  may  develop  into  plasma 
cells and contribute to serum autoantibody production, which 
may be a rare event given the high frequencies of polyreactive 
and self-reactive GC B cells in the absence of FcRIIB. Com-
petition for antigen presented in the form of immune com-
plexes on follicular dendritic cells has been considered a 
bottleneck for selection of antigen-specific GC B cells. FcRIIB 
is expressed on follicular dendritic cells, but the B cell–intrinsic 
importance of FcRIIB for the development of autoimmu-
nity has been demonstrated by bone marrow transfer and cell-
specific  overexpression  experiments  (Bolland  and  Ravetch, 
2000; McGaha et al., 2005; Brownlie et al., 2008). Further-
more, recent evidence suggests that selection of GC B cells is 
limited predominantly by competition for access to T follicu-
lar helper cells, which play an important role in preventing 
the differentiation of autoreactive GC B cells into effector   
B cells (Haberman and Shlomchik, 2003; Allen et al., 2007).
Spleen and bone marrow harbor niches for long-term 
plasma cell survival, and clonally related cells were frequently 
found in both organs (Manz et al., 1997; Slifka et al., 1998). 
However, spleen plasma cells had, on average, lower muta-
tion numbers and were enriched for polyreactivity, suggest-
ing that the spleen harbors a pool of plasma cells, which are 
excluded from the bone marrow under physiological circum-
stances. Marginal zone B cell and B1 cell–derived plasma cells 
expressing  natural  polyreactive  and  low  level  self-reactive   
antigen receptors may contribute to the relative increase in 
polyreactive spleen plasma cells not observed in bone mar-
row (Martin and Kearney, 2000). However, the develop-
ment of IgG autoantibodies and lupus disease in FcRIIB/ 
mice strictly depends on T cell help, suggesting that T cell–
independent MZ and B1 cell–derived plasma cells do not 
contribute to pathogenicity.
In summary, our analysis allowed, for the first time, the 
dissection of the GC and plasma cell antibody response under 
physiological circumstances on a cellular level. The data 
demonstrate an important role for FcRIIB in the regulation 
of autoreactive IgG+ GC B cells, which develop from non-
self–reactive or low-level self-reactive precursors by somatic 
a major role in the development of IgG autoantibodies in 
terminal  deoxynucleotidyl  transferase–deficient  lupus  mice 
(Guo et al., 2010). Lack of negative signaling by FcRIIB 
may specifically favor the accumulation of T cell–dependent 
chromatin-reactive GC B cells and, ultimately, the develop-
ment of lupus disease as a result of the strong BCR cross-
linking capacity of abundant DNA- and RNA-containing 
self-antigens,  which  promote  activation  of  autoreactive   
Figure 7.  Somatic mutations generate specific high-affinity  
T cell–dependent autoantibodies in FcRIIB/ mice. (A) ANA-ELISA–
reactive IgG2b and IgG2c autoantibodies in diluted serum (1:100) from 
FcRIIB/ and FcRIIB/TCR-/ mice. Horizontal lines indicate mean 
OD405 values. Error bars indicate standard deviation. (B) Indirect immuno-
fluorescence staining patterns of mutated kidney (K) and stomach (S) 
tissue-reactive antibodies and of their unmutated GL forms cloned from 
FcRIIB/ mice are shown (20× magnification). Bars, 100 µm. (C) Anti-
IgG2c ELISA for the mutated IgG2c-specific rheumatoid factor antibody 
lnpc203 (closed circles) and its unmutated GL form (open circles).  
(D) Anti-nucleosome ELISA for the mutated (filled circles) and GL (open 
circles) form of the nucleosome-specific antibody 1RIIspc194. (E) Anti-
dsDNA ELISA of the mutated (closed circles) and GL (open circles) form of 
the anti-dsDNA 1RIIgc7. dsDNA reactivity of unmutated 1RIIgc7 is 
abrogated if two IgH CDR3 arginine residues are replaced by serines  
(GL 1RII-gc7S, squares). Horizontal lines in C–E show cutoff OD405 values  
for reactive (top) and nonreactive (bottom) antibodies. Graphs are  
representative of at least two independent experiments.2776 FcRIIB regulates germinal center B cells | Tiller et al.
to framework region 3, inclusively, as defined by the Ig Blast. Isotype sub-
classes were determined by comparison to the annotated sequences on the   
International ImMunoGeneTics homepage (http://imgt.cines.fr) or to the ge-
nomic C57BL/6 reference sequence of the National Center for Biotechnol-
ogy Information m37 assembly (accessed via http://www.ensembl.org).
Antibody production, ELISA, and IFA. Ig gene cloning and antibody 
expression was performed as previously described (Tiller et al., 2009). In brief, 
mouse variable region genes were cloned into expression vectors encoding 
the human constant Ig1 and Ig regions, respectively, to generate chimeric 
recombinant antibodies (Tiller et al., 2009). Recombinant monoclonal anti-
bodies were expressed in human embryonic kidney HEK293T cells and su-
pernatants of known antibody concentrations were tested for polyreactivity 
with dsDNA, insulin, and LPS as previously described (Wardemann et al., 
2003; Tiller et al., 2008). Commercially available nucleosome, dsDNA, and 
histone diagnostic ELISAs (all from Orgentec) were performed under block-
ing conditions with 2% BSA. Nucleosome ELISAs were internally con-
trolled using commercially available anti-nucleosome IgG-positive human 
control serum (Orgentec). Protein G purified antibodies were tested for self-
reactivity with fixed HEp-2 cells, Crithidia luciliae, and fixed mouse stomach 
and kidney sections (all from Orgentec) by IFA at 100 µg/ml under moist 
conditions at room temperature. Polyclonal goat anti–human IgG–cyanine 3 
(Jackson ImmunoResearch Laboratories) was used at a 1:500 dilution to de-
tect bound recombinant antibodies. Mouse sera were tested at 1:100 dilu-
tions for reactivity with HEp-2 cells by IFA and by ANA Detect ELISA 
(both Orgentec). Bound serum IgG antibodies were detected using individ-
ual or mixed FITC-labeled polyclonal goat anti–mouse IgG1, IgG2b, IgG2c, 
and IgG3 antibodies (all from Bethyl Laboratories, Inc.). 1 µg/ml Hoechst 
33343 (Invitrogen) was used to counterstain cell nuclei. Serum IgG reactiv-
ity with dsDNA, nucleosomes, and IgG antibodies (rheumatoid factor re-
activity) was tested by ELISA at 1:100 mouse serum dilutions (all from 
Orgentec). Bound serum IgG antibodies were detected using horseradish 
peroxidase–labeled polyclonal goat anti–mouse IgG2b and IgG2c antibodies 
(all from Bethyl Laboratories, Inc.). Slides were mounted with Fluoromount 
G (SouthernBiotech) and examined on a fluorescence microscope (Axioplan 
2; Carl Zeiss, Inc.). Control stainings with PBS and control sera were per-
formed as suggested by the manufacturer and were included in all experi-
ments. All images were acquired at equal exposure times.
Ig gene reversion of somatic mutations. Somatically mutated Ig genes 
were reverted into their unmutated GL counterparts using an overlap PCR 
strategy as previously described (Tiller et al., 2008). In brief, GL V gene tran-
scripts were amplified from previously cloned unmutated V genes amplified 
from naive B cells. Mutated CDR3-J sequences were reverted independently 
by PCR using forward primers with a minimum of 10 nt complementary to 
the GL V gene PCR product in combination with J gene–specific reverse 
primers. PCRs were performed at 94°C for 30 s, 58°C for 30 s, and 72°C for 
45 s for 30 cycles. Equal ratios of the reverted V and CDR3-J gene PCR 
products were fused under the same conditions in a third 20-cycle overlap 
PCR with V gene and J gene-specific primers containing restriction sites, 
which allow direct expression vector cloning. The successful reversion of so-
matic mutations was confirmed by sequence analysis of the cloned products.
Statistics.  P-values  for  Ig  gene  repertoire  analyses,  analysis  of  positive 
charges in IgH CDR3, and antibody reactivity were calculated by 2 × 2 or 
2 × 5 Fisher’s Exact test or 2 test. P-values for IgH CDR3 aa length were 
calculated by Student’s t test. P-values for V gene somatic mutation numbers 
were calculated by Mann-Whitney Wilcoxon test.
Online supplemental material. Fig. S1 shows representative FACS plots 
of mature naive B cells, GC B cells, and spleen and bone marrow plasma cells   
of FcRIIB/ and wild-type mice, FcRIIB/ spleen IFA for GL7/IgM/
CD4, MOMA-1/IgG2b/c, and GL7/IgG2b/c, and representative nuclear 
HEp-2 cell IFA staining patterns of IgG serum antibodies from FcRIIB/ 
and wild-type mice. Figs. S2 and S3 provide detailed information on the 
mutations. FcRIIB has been shown to control plasma cell 
homeostasis (Xiang et al., 2007). However, the development 
of high-affinity autoreactive IgG+ plasma cells in FcRIIB/ 
mice is a relatively rare event given the high numbers of auto-
reactive IgG+ GC B cells, and we did not observe any signs 
for the preferential clonal expansion of chromatin-reactive   
B cells. The findings suggest the existence of an FcRIIB- 
independent checkpoint for autoreactivity before develop-
ment of GC B cells into spleen or bone marrow plasma cells, 
which has been predicted previously by observations made in 
Ig gene transgenic mice (Erikson et al., 1991; Culton et al., 
2006). Accumulation of T cell–dependent high-affinity auto-
reactive IgG+ GC B cells over time and limited differentia-
tion of such cells into plasma cells may explain the late onset 
of autoantibody development and lupus disease in the ab-
sence of FcRIIB.
MATERIALS AND METHODS
Mice.  C57BL/6  mice  were  purchased  from  Charles  River  Laboratories. 
FcRIIB-deficient C57BL/6 mice (B6.129S4-Fcgr2btm1Ttk) were supplied by 
J. Ravetch (The Rockefeller University, New York; NY; Takai et al., 1996; 
Bolland and Ravetch, 2000). TCR-–deficient mice (B6.129P2-Tcrbtm1Mom/J; 
The Jackson Laboratory) were bred to FcRIIB-deficient C57BL/6 mice 
(B6.129S4-Fcgr2btm1Ttk)  to  obtain  FcRIIB/TCR-/  mice.  All  mice 
were maintained under specific pathogen-free conditions. Animal experi-
ments were approved by the Landesamt für Gesundheit und Soziales, Berlin.
Flow cytometry. For FACS analyses, the following anti–mouse antibodies 
were used according to standard protocols: anti–CD138-PE (clone N418), 
anti–Fas-PE  (clone  Jo2),  anti–GL7-FITC  (clone  GL7),  anti–IgD-biotin 
(clone  11.26c),  anti–B220–peridinin  chlorophyll  protein  complex  (clone 
RA3-6B2), anti–CD21-FITC (clone 7G6), anti–CD23-biotin (clone B3/B4), 
anti–IgM–cyanine 5 (clone M41), and streptavidin-PE (all obtained from 
BD or in house-preparations).
Single  B  cell  sorting  and  Ig  gene  cloning.  Single  cell  sorting,   
RT-PCR, and Ig gene cloning were performed as previously described   
(Tiller et al., 2009). In brief, single CD21dullCD23+IgM+B220+ mature naive 
B cells, FAS+GL7+IgD GC splenocytes, and CD138high plasma cells from 
spleen and bone marrow of the indicated mice were isolated into 96-well 
PCR plates using a FACSVantage cell sorter with DiVa option (BD). GC   
B cells from immunized C57BL/6 mice (n = 3) were isolated from pooled 
draining lymph nodes at days 10, 14, and 21, respectively, after subcutaneous 
immunization with a mixture of 100 µg OVA in 50 µl PBS (EMD) and   
50 µl CFA (Sigma-Aldrich). Cells were lysed and cDNA was prepared as de-
scribed. IgH chain and Ig light chain gene transcripts were amplified by 
seminested PCR for IgM (naive mature B cells) or IgG (GC B cells and 
plasma cells) heavy chain and by nested PCR for Ig, respectively (Tiller   
et al., 2009). PCR products were sequenced.
Ig gene sequence analysis. Ig gene nucleotide sequences (Tables S2–S4,   
accession numbers FR688150–FR689535) are available from the European 
Molecular Biology Laboratory Nucleotide Sequence Database (http://www 
.ebi.ac.uk/embl/). Ig gene sequence analysis was performed by IgBlast (http://
www.ncbi.nlm.nih.gov/igblast/) to identify GL V(D)J genes with highest   
homology. IgH CDR3 was defined as the sequence between the conserved 
VH gene encoded cysteine at Kabat position 92 (International ImMunoGe-
neTics 104) and the tryptophan at Kabat position 103 (International ImMuno-
GeneTics 118) encoded by the JH gene (Ivanov et al., 2005). Ig DH gene RF 
was annotated as defined by Ichihara et al. (1989). Numbers of positively 
charged amino acids in IgH CDR3 summarize the number of arginines, ly-
sines, and histidines. Somatic mutations were counted in V genes from CDR1 JEM VOL. 207, November 22, 2010 
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